Alleviating alcohol dependency with Association Olivier Ameisen
Issue and change management
The Association Olivier Ameisen selected Spark Change for media relations support associated with prescription of the drug Baclofen, for the treatment of alcohol dependency. Spark Change provided counsel on a media relations strategy and messaging. Baclofen, is a relaxant commonly used to treat multiple sclerosis. Following much media campaigning, ANSM, the French drug authority, licensed Bacolfen in 2014 as an alcoholism treatment.